This week we highlight vaccine mandate considerations, the lack of diversity on the boards of life sciences companies, a promising new class of drugs and more. … READ MORE >
FDA
5 things to know in life sciences: Week of March 22
This week we highlight AstraZeneca-Oxford COVID-19 vaccine challenges, FDA trends, drug-pricing reform hearings and more. … READ MORE >
Coronavirus disrupts the pipeline for new drugs and medical devices
On Tuesday, a day before the World Health Organization declared the coronavirus outbreak a pandemic, the Food and Drug Administration announced that it was postponing foreign inspections through April. … READ MORE >